Mary H. Latka

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Glenda Gray, Mary Allen, Zoe Moodie et al. · The Lancet Infectious Diseases · 2011 · 382 citations · Full text

Vaccination, Hvtn 503/Phambili, Human Retrovirus +9

Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004

Joseph J Amon, Richard S. Garfein, Linda Ahdieh‐Grant et al. · Clinical Infectious Diseases · 2008 · 198 citations

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

Richard S. Garfein, Elizabeth T. Golub, Alan E. Greenberg et al. · AIDS · 2007 · 167 citations

Correlates of Lending Needles/Syringes Among HIV-Seropositive Injection Drug Users

Lisa R. Metsch, Margaret Pereyra, David W. Purcell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 159 citations

Substance Use, Mental Health, Drug Treatment +21

Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities

Holly Hagan, Enrique R. Pouget, Ian T. Williams et al. · The Journal of Infectious Diseases · 2010 · 127 citations · Full text

Injection Drug Users, Substance Use, Vaccine Hesitancy +18